Burzynski Research
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting se… Read more
Burzynski Research (BZYR) - Total Assets
Latest total assets as of November 2025: $2.27K USD
Based on the latest financial reports, Burzynski Research (BZYR) holds total assets worth $2.27K USD as of November 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Burzynski Research - Total Assets Trend (1998–2025)
This chart illustrates how Burzynski Research’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Burzynski Research - Asset Composition Analysis
Current Asset Composition (February 2025)
Burzynski Research's total assets of $2.27K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 100.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1998–2025)
This chart illustrates how Burzynski Research's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Burzynski Research's current assets represent 100.0% of total assets in 2025, an increase from 1.5% in 1998.
- Cash Position: Cash and equivalents constituted 100.0% of total assets in 2025, up from 1.5% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Burzynski Research Competitors by Total Assets
Key competitors of Burzynski Research based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Burzynski Research - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Burzynski Research generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Burzynski Research is currently not profitable relative to its asset base.
Burzynski Research - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.03 | 0.03 | 0.02 |
| Quick Ratio | 0.03 | 0.03 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-67.34K | $ -21.33K | $ -45.84K |
Burzynski Research - Advanced Valuation Insights
This section examines the relationship between Burzynski Research's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2190.81 |
| Latest Market Cap to Assets Ratio | 1444.47 |
| Asset Growth Rate (YoY) | -63.3% |
| Total Assets | $847.00 |
| Market Capitalization | $1.22 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Burzynski Research's assets at a significant premium ( 1444.47x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Burzynski Research's assets decreased by 63.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Burzynski Research (1998–2025)
The table below shows the annual total assets of Burzynski Research from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-02-28 | $847.00 | -63.33% |
| 2024-02-29 | $2.31K | +19.44% |
| 2023-02-28 | $1.93K | -58.51% |
| 2022-02-28 | $4.66K | +387.55% |
| 2021-02-28 | $956.00 | -95.18% |
| 2020-02-29 | $19.85K | -10.46% |
| 2019-02-28 | $22.17K | -23.36% |
| 2018-02-28 | $28.93K | +169.58% |
| 2017-02-28 | $10.73K | +169.15% |
| 2016-02-29 | $3.99K | +9.29% |
| 2015-02-28 | $3.65K | +59.93% |
| 2014-02-28 | $2.28K | -41.93% |
| 2013-02-28 | $3.93K | -81.04% |
| 2012-02-29 | $20.72K | -4.07% |
| 2011-02-28 | $21.60K | -6.01% |
| 2010-02-28 | $22.98K | +39.63% |
| 2009-02-28 | $16.46K | +59.60% |
| 2008-02-29 | $10.31K | -20.23% |
| 2007-02-28 | $12.93K | -39.65% |
| 2006-02-28 | $21.42K | -67.48% |
| 2005-02-28 | $65.85K | -11.14% |
| 2004-02-29 | $74.11K | +12.69% |
| 2003-02-28 | $65.77K | -28.39% |
| 2002-02-28 | $91.84K | -19.23% |
| 2001-02-28 | $113.71K | -41.57% |
| 2000-02-29 | $194.59K | -42.55% |
| 1999-02-28 | $338.70K | -22.68% |
| 1998-02-28 | $438.06K | -- |